An HPLC-UV validated bioanalytical method for measurement of phase 1 kinetics of α-synuclein binding bifunctional compounds.

Aggregates of the protein α-synuclein are associated with pathophysiology of Parkinson's disease and are present in Lewy Bodies found in the brains of Parkinson's patients. We previously demonstrated that bifunctional compounds composed of caffeine linked via a six carbon chain to either 1-aminoindan (C-6-I) or nicotine (C-6-N) bind α-synuclein and protect yeast cells from α-synuclein mediated toxicity.A critical step in development of positron emission tomography (PET) probes for neurodegenerative diseases is evaluation of their metabolic stability.

Employing metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds.

A challenge in the development of novel F-labelled positron emission tomography (PET) imaging probes is identification of metabolically stable sites to incorporate the F radioisotope. Metabolic loss of F from PET probes can lead to misleading biodistribution data as displaced F can accumulate in various tissues.In this study we report on hepatic microsomal metabolism of novel caffeine containing bifunctional compounds (C-6-I, C-6-N, C-6-C) that can prevent aggregation of α-synuclein, which is associated with the pathophysiology of Parkinson's disease.

Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting.

The engineering of T cells through expression of chimeric antigen receptors (CARs) against tumor-associated antigens (TAAs) has shown significant potential for use as an anti-cancer therapeutic. The development of strategies for flexible and modular CAR T systems is accelerating, allowing for multiple antigen targeting, precise programming, and adaptable solutions in the field of cellular immunotherapy. Moving beyond the fixed antigen specificity of traditional CAR T systems, the modular CAR T technology splits the T cell signaling domains and the targeting elements through use of a switch molecule.

Establishment of correctly focused eyes may not require visual input in arthropods.

For proper function, vertebrate and invertebrate visual systems must be able to achieve and maintain emmetropia, a state where distant objects are in focus on the retina. In vertebrates, this is accomplished through a combination of genetic control during early development and homeostatic visual input that fine-tunes the optics of the eye. While emmetropization has long been researched in vertebrates, it is largely unknown how emmetropia is established in arthropods.

Giving invertebrates an eye exam: an ophthalmoscope that utilizes the autofluorescence of photoreceptors.

One of the most important functional features of eyes is focusing light, as both nearsightedness and farsightedness have major functional implications. Accordingly, refractive errors are frequently assessed in vertebrates, but not in the very small invertebrate eyes. We describe a micro-ophthalmoscope that takes advantage of autofluorescent properties of invertebrate photoreceptors and test the device on the relatively well-understood eyes of jumping spiders and flies.